Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Hadjigeorgiou

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|December 13, 2021
Tetracyclines Diminish <i>In Vitro</i> IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple SclerosisDespoina T Florou, Athanasios Mavropoulos, Efthymios Dardiotis, et al.
Archives of Neurology|October 12, 2005
Delusions and hallucinations are associated with worse outcome in Alzheimer diseaseNikolaos Scarmeas, Jason Brandt, Marilyn Albert, et al.
Aging & Mental Health|January 20, 2021
The factors associated with the presence of psychotic symptoms in the HELIAD Greek community study of older adultsHelen-Maria Vasiliadis, Rossetos Gournellis, Vasiliki Efstathiou, et al.
Parkinsonism & Related Disorders|April 18, 2021
Late life psychotic features in prodromal Parkinson's diseaseIoanna Pachi, Maria I Maraki, Nikolaos Giagkou, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
BMJ Neurology Open|November 10, 2022
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL StudyMarios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, et al.
Sleep Medicine|July 25, 2016
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundationDiego Garcia-Borreguero, Michael H Silber, John W Winkelman, et al.
Radiology Research and Practice|August 1, 2012
Preoperative evaluation with FMRI of patients with intracranial gliomasIoannis Z Kapsalakis, Eftychia Z Kapsalaki, Efstathios D Gotsis, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 8, 2020
Frailty and Prodromal Parkinson's Disease: Results From the HELIAD StudyEva Ntanasi, Maria Maraki, Mary Yannakoulia, et al.
Glia|April 28, 2015
Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitisPaschalis Theotokis, Kleopas A Kleopa, Olga Touloumi, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|December 13, 2021
Tetracyclines Diminish <i>In Vitro</i> IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple SclerosisDespoina T Florou, Athanasios Mavropoulos, Efthymios Dardiotis, et al.
Archives of Neurology|October 12, 2005
Delusions and hallucinations are associated with worse outcome in Alzheimer diseaseNikolaos Scarmeas, Jason Brandt, Marilyn Albert, et al.
Aging & Mental Health|January 20, 2021
The factors associated with the presence of psychotic symptoms in the HELIAD Greek community study of older adultsHelen-Maria Vasiliadis, Rossetos Gournellis, Vasiliki Efstathiou, et al.
Parkinsonism & Related Disorders|April 18, 2021
Late life psychotic features in prodromal Parkinson's diseaseIoanna Pachi, Maria I Maraki, Nikolaos Giagkou, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
BMJ Neurology Open|November 10, 2022
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL StudyMarios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, et al.
Sleep Medicine|July 25, 2016
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundationDiego Garcia-Borreguero, Michael H Silber, John W Winkelman, et al.
Radiology Research and Practice|August 1, 2012
Preoperative evaluation with FMRI of patients with intracranial gliomasIoannis Z Kapsalakis, Eftychia Z Kapsalaki, Efstathios D Gotsis, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 8, 2020
Frailty and Prodromal Parkinson's Disease: Results From the HELIAD StudyEva Ntanasi, Maria Maraki, Mary Yannakoulia, et al.
Glia|April 28, 2015
Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitisPaschalis Theotokis, Kleopas A Kleopa, Olga Touloumi, et al.
Pageof 11